Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Alexei A. von Delwig"'
Publikováno v:
Exploration of Immunology, Vol 3, Iss 5, Pp 506-512 (2023)
Immunotherapeutic treatment of autoimmune diseases should aim to inactivate autoaggressive memory T-cells and restore immune tolerance. It is envisaged that three approaches could be used to achieve this goal: stimulation of anti-idiotypic immune res
Externí odkaz:
https://doaj.org/article/d9b5aac3bdc04ce98636de516656ca77
Publikováno v:
Metabolites, Vol 12, Iss 12, p 1160 (2022)
Cellular senescence is conditioned through two interrelated processes, i.e., a reduction in adenosine triphosphate (ATP) and the enhancement of reactive oxygen species (ROS) production levels in mitochondria. ATP shortages primarily influence the ene
Externí odkaz:
https://doaj.org/article/a618c45582c34de39dc0910aaa79ad47
Publikováno v:
Expert Review of Anticancer Therapy. 22:575-581
The metabolic environment in ischemic and hypoxic tumors is known to contribute to cancer progression. Importantly, peculiar metabolic changes occurring in malignant cells (the increased glycolysis and the hampered Krebs cycle) may contribute to decr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab5dc5351e1d9bc926ba875ce368496f
https://doi.org/10.1080/14737140.2022.2070153
https://doi.org/10.1080/14737140.2022.2070153
Publikováno v:
Expert opinion on biological therapy. 21(3)
The immune system is able to exert both tumor-destructive and tumor-protective functions. Immunotherapeutic technologies aim to enhance immune-based anti-tumor activity and (or) weaken tumor-protective immunity.Cancer vaccination, antibody (Ab)-media
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdf21b4ad98ee865d26e9e5bfea60378
https://pubmed.ncbi.nlm.nih.gov/32981358
https://pubmed.ncbi.nlm.nih.gov/32981358
Autor:
Seledtsov VI; Innovita Research Company, 06116 Vilnius, Lithuania.; Russian Scientific Center of Surgery Named after Academician B.V. Petrovsky, 119991 Moscow, Russia., Darinskas A; National Cancer Institute, 08406 Vilnius, Lithuania., Von Delwig A; Innovita Research Company, 06116 Vilnius, Lithuania., Seledtsova GV; Institute for Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia.
Publikováno v:
Metabolites [Metabolites] 2023 Jan 13; Vol. 13 (1). Date of Electronic Publication: 2023 Jan 13.
Autor:
Seledtsov VI; Center for Integral Immunotherapy, Central Clinical Hospital of the Russian Academy of Sciences, Moscow, Russia.; Department of Immunology, Innovita Research Company, Vilnius, Lithuania., von Delwig A; Department of Immunology, Innovita Research Company, Vilnius, Lithuania.
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2021 Mar; Vol. 21 (3), pp. 323-342. Date of Electronic Publication: 2020 Oct 03.
Autor:
Boghossian S; Birmingham Heartlands Hospital, NHS, Birmingham, West Midlands, UK. shaboghru@gmail.com, Robinson S, Von Delwig A, Manas D, White S
Publikováno v:
Surgical oncology [Surg Oncol] 2012 Jun; Vol. 21 (2), pp. 67-77. Date of Electronic Publication: 2011 Feb 02.
Autor:
Ng WF; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom., Tudhope SJ, von Delwig A, Lilic D
Publikováno v:
Immunology letters [Immunol Lett] 2011 Mar 30; Vol. 135 (1-2), pp. 180-3. Date of Electronic Publication: 2010 Oct 12.
Autor:
Stoop JN; Newcastle University, Newcastle upon Tyne, UK., Harry RA, von Delwig A, Isaacs JD, Robinson JH, Hilkens CM
Publikováno v:
Arthritis and rheumatism [Arthritis Rheum] 2010 Dec; Vol. 62 (12), pp. 3656-65.
Autor:
Ng WF; Musculoskeletal Research Group, Institute for Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., von Delwig A, Carmichael AJ, Arkwright PD, Abinun M, Cant AJ, Jolles S, Lilic D
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2010 Nov; Vol. 126 (5), pp. 1006-15, 1015.e1-4. Date of Electronic Publication: 2010 Oct 08.